It is a product of Novo Nordisk that contains semaglutide as its active ingredient
While there are potential risks, careful monitoring allows any issues to be picked up and addressed early
For non-prescription supplement drops, you must strictly follow the manufacturer's recommended dosage on the product label, as formulations vary widely
Step up every 4 weeks: 0.5mg, 1mg, 1.7mg, then 2.4mg maintenance
The prescribing note should include: the patient's current HbA1c or BMI with date of measurement, a chronological list of all prior therapies with dates and reasons for discontinuation, a statement of why liraglutide specifically is preferred over other non-preferred agents (for example, the cardiovascular outcome benefit documented in LEADER [5] for a patient with known coronary artery disease), and a direct reference to the applicable ADA or Endocrine Society guideline recommendation [6][8]
Dullness is